CEO: Hinnerk Boriss
Wellington contact:
Rainer Strohmenger
| Lowering the costs of drug development |
Sovicell (formerly called Nimbus) offers bioanalytical products and services to pharma companies in the field of early ADMET prediction (adsorption, distribution, metabolism, excretion, toxicology). The company’s products are based on a proprietary technology platform. Nimbus helps its customers sort out unsuccessful drug candidates early on in the drug discovery process, thus lowering costs and accelerating development.
First investment: December 1998
Sovicell GmbH
Deutscher Platz 5b
04103 Leipzig
Germany
